30.6.2025 08:00:00 CEST | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state
Aqua Bio Technology ASA has appointed Kristian Flaten as Chief Executive Officer, effective from 1 August 2025.
During an interim period, Kristian will also hold the position as Chief Financial Officer.
Kristian Flaten brings over 25 years of financial and business leadership, with proven track record in management, finance, corporate governance and business development from listed growth companies and international organisations.
Kristian has a background as CFO with IDEX Biometrics ASA and Quantafuel ASA, with additional experience from BW Offshore, Eksportkreditt (Eksfin) and Handelsbanken.
Kristian holds a Master of Science from NHH (Norwegian School of Economics), with majors in Finance and Strategy.
The board of Aqua Bio Technology has previously announced that the company will enter a phase with new priorities and cost adjustments. The board will conclude on these topics during the second half of 2025.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
Roger Sedal, Chair of the Board of Directors, Aqua Bio Technology ASA, +4740002002, roger@sedal.no
Terje Blytt, JetCarrier AS, +4769184030
About Aqua Bio Technology ASA
Aqua Bio Technology ASA (ABTEC) is a distribution group i skincare and non-food. The group has distribution towards B2C, B2B, B2B2, and freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo. market of the Oslo Stock Exchange.
Attachments
Download announcement as PDF.pdf
30.6.2025 08:00:00 CEST | Aqua Bio Technology ASA | Annen informasjonspliktig regulatorisk informasjon
Aqua Bio Technology ASA har engasjert Kristian Flaten som administrerende direktør (CEO) fra 1.august 2025.
Kristian vil inntil videre også fungere som selskapets finansdirektør (CFO).
Kristian har over 25 års erfaring fra finans og næringsliv, inkludert ledelse, finansiering, corporate governance og forretningsutvikling fra børsnoterte vekstselskaper og internasjonale selskaper.
Kristian har tidligere erfaring som CFO fra IDEX Biometrics ASA og Quantafuel ASA, og har ytterligere bakgrunn fra blant annet BW Offshore, Eksportkreditt (Eksfin) og Handelsbanken.
Kristian er siviløkonom fra NHH (Norges Handelshøyskole).
Styret i Aqua Bio Technology har tidligere annonsert at selskapet går inn i en fase med nye prioriteringer og kostnadsjusteringer. Styret vil presentere dette i løpet av andre halvår 2025.
Informasjonspliktig opplysning
Denne opplysningen er informasjonspliktig etter verdipapirhandelloven § 5-12.
Kontakter
Roger Sedal, Chair of the Board of Directors, Aqua Bio Technology ASA, +4740002002, roger@sedal.no
Terje Blytt, JetCarrier AS, +4769184030
Om Aqua Bio Technology ASA
Aqua Bio Technology ASA (ABTEC) er et distribusjonskonsern innen hudpleie og nonfood. Konsernet har distribusjon mot B2C, B2B, B2B2 og frakt-, fortolling- og logistikktjenester. Konsernet utvikler også bærekraftig bioteknologi for bruk i hudpleieprodukter. Aqua Bio Technology er notert på Euronext Expand Oslo.
Vedlegg
Last ned som PDF.pdf
